Cancer Care

Graphic: Cancer Care Banner
 

 

Prostate & Genitourinary Cancer Clinical Trials

A clinical trial is one of the final steps in a long and careful cancer research process that is looking for better ways to prevent, diagnose, or treat cancer. Clinical trials test new medical approaches in patients with cancer, and are important to developing new treatments for cancer. Many of the "standard treatments" that patients with cancer receive today were developed based on the results of previous clinical trials.

The following is a list of clinical trials with which this cancer care program is currently involved. Talk to your doctor to find out if a clinical trial is right for you.

Kidney Clinical Trials
A Randomized Phase 3 Study of LY2835219 plus Best Supportive Care versus Erlotinib plus Best Supportive Care in Patients with Stage IV NSCLC with a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy
Kidney
F14178
Dragnev
ASSURE: Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma
Kidney
E2805
Seigne
Immunologic Evaluation of Peripheral Blood
Kidney
D0229
Fadul
Melanoma and Renal Tumor Tissue Bank
Kidney
D1013
Seigne
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Kidney
FED11061
Pace
Renal Tumors Classification, Biology and Banking Study
Kidney
AREN03B2
Chaffee
Other Male Genital Clinical Trials
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Male Genital
FED11061
Pace
Other Urinary Clinical Trials
Immunologic Evaluation of Peripheral Blood
Other Urinary
D0229
Fadul
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Other Urinary
FED11061
Pace
Prostate Clinical Trials
A Phase 2 Study of recombinant glycosylated human interleukin-7 (CYT107) after completion of standard FDA approved therapy with sipuleucel-T (Provenge?) for patients with asymptomatic or minimally symptomatic metastatic castration-resistant prostate cancer (mCRPC)
Prostate
W13155
Seigne
A Phase III Prospective Randomized Trial Of Dose-Escalated Radiotherapy With Or Without Short-Term Androgen Deprivation Therapy For Patients With Intermediate-Risk Prostate Cancer
Prostate
R0815
Hartford
A Phase III Trial Of Short Term Androgen Deprivation With Pelvic Lymph Node Or Prostate Bed Only Radiotherapy (SPPORT) In Prostate Cancer Patients With A Rising Psa After Radical Prostatectomy
Prostate
R0534
Hartford
A Phase III Trial of the Study of Endocrine Therapy Used as a Cytoreductive and Cytostatic Agent Prior to Radiation Therapy in Good Prognosis Locally Confined Adenocarcinoma of the Prostate
Prostate
R9408
Hartford
A Phase III Trial to Evaluate the Duration of Neoadjuvant Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate Risk Prostate Cancer
Prostate
R9910
Hartford
Adjuvant Androgen Deprivation Versus Mitoxantrone Plus Prednisone Plus Androgen Deprivation in Selected High Risk Prostate Cancer Patients Following Radical Prostatectomy, Phase III
Prostate
C99904
Seigne
Androgen Deprivation Therapy and High Dose Radiotherapy with or without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Prostate
R0924
Hartford
Electrical Property Based Image-Guided Prostate Biopsy
Prostate
D1041
Halter
Phase III Trial of Enzalutamide (NSC #766085) versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer
Prostate
A031201
Devitskiy
Randomized Phase III Study of Neo-Adjuvant Docetaxel and Androgen Deprivation Prior to Radical Prostatectomy versus Immediate Radical Prostatectomy in Patients with High-Risk, Clinically Localized Prostate Cancer
Prostate
C90203
Seigne
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Prostate
FED11061
Pace
Surgical Margin Assessment During Radical Prostatectomy - a Deformation Study
Prostate
D1003
Halter
Urinary Bladder Clinical Trials
A Phase I/II Trial of A Combination of Paclitaxel and Trastuzumab with Daily Irradiation OR Paclitaxel Alone with Daily Irradiation Following Transurethral Surgery for Non-Cystectomy Candidates with Muscle-Invasive Bladder Cancer
Urinary Bladder
R0524
Hartford
A Phase II Protocol For Patients With Stage T1 Bladder Cancer To Evaluate Selective Bladder Preserving Treatment By Radiation Therapy Concurrent With Cisplatin Chemotherapy Following A Thorough Transurethral Surgical Re-Staging
Urinary Bladder
R0926
Hartford
A Randomized Double-Blind Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma
Urinary Bladder
C90601
Devitskiy
A Tumor Tissue Pharmacodynamic Study of Modified Neoadjuvant Chemotherapy for Muscle-invasive Non-metastatic Transitional Cell Bladder Carcinoma
Urinary Bladder
D12064
Lewis
Immunologic Evaluation of Peripheral Blood
Urinary Bladder
D0229
Fadul
Randomized Phase II Trial Of Postoperative Adjuvant IMRT Following Cystectomy For pt3/pt4 Urothelial Bladder Cancer
Urinary Bladder
NRG-GU001
Hartford
Reducing Disparities in Health for Vulnerable Populations in NH and VT: Journey Forward Cancer Survivor Care Planning in the Rural Northeast
Urinary Bladder
FED11061
Pace